Abstract
Advances in molecular biology and the understanding of the molecular basis of many diseases have provided tools necessary for a new approach to the treatment of both inherited and acquired diseases. This approach, called gene therapy, was initially focused on the correction of inherited diseases for which no therapeutic approaches were available (1,2). However, it is now clear that the technique of gene therapy can potentially be applied to the local, temporary treatment of acquired diseases, including impaired wound healing and tissue repair (3). Gene therapy is becoming a reality, and it is a particularly attractive approach for wound healing, since the wound site is often exposed, the treatment and condition should be transient, and gene products such as growth factors and cytokines suffer from problems with bioavailability and stability. Such approaches are often innovative and provide solutions to the problems inherent in cell-based drug delivery methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson, W. F. (1984) Prospects for human gene therapy. Science 226, 401ā409.
Anderson, W. F. (1992) Human gene therapy. Science 256, 808ā813.
Davidson, J. M., Whitsitt, J. S., Pennington, B., Ballas, C. B., Eming, S. and Benn, S. I. (1999) Gene therapy of wounds with growth factors. Curr. Top. Pathol. 93, 111ā121.
Martin, P. (1997) Wound healingāaiming for perfect skin regeneration. Science 276, 75ā81.
Hoff, C. R. and Davidson, J. M. (1996) Cellular and biochemical mechanisms of wound repair, in Cellular and Biochemical Mechanisms of Wound Repair (Lonai, P., ed.), Harwood, London, pp. 293ā320.
Singer, A. J. and Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738ā746.
Falanga, V. (1993) Chronic wounds: pathophysiologic and experimental considerations. J. Invest. Dermatol. 100, 721ā725.
Falanga, V. (1992) Growth factors and chronic wounds: the need to understand the microenvironment. J. Dermatol. 19, 667ā672.
Bennett, N. T. and Schultz, G. S. (1993) Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am. J. Surg. 165, 728ā737.
Bennett, N. T. and Schultz, G. S. (1993) Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am. J. Surg. 166, 74ā81.
Pierce, G. F. and Mustoe, T. A. (1995) Pharmacologic enhancement of wound healing. Annu. Rev. Med. 46, 467ā481.
Lauer, G., Sollberg, S., Cole, M., Flamme, I., Sturzebecher, J., Mann, K., Krieg, T., and Eming, S. A. (2000) Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 115, 12ā18.
Eming, S. A., Morgan, J. R., and Berger, A. (1997) Gene therapy for tissue repair: approaches and prospects. Br. J. Plast. Surg. 50, 491ā500.
Friedmann, T. (1992) A brief history of gene therapy. Nat. Genet. 2, 93ā98.
Chandler, L. A., Doukas, J., Gonzalez, A. M., et al. (2000) FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol. Ther. 2, 153ā160.
Spector, J. A., Mehrara, B. J., Luchs, J. S., Greenwald, J. A., Fagenholz, P. J., Saadeh, P. B., Steinbrech, D. S., and Longaker, M. T. (2000) Expression of adenovirally delivered gene products in healing osseous tissues. Ann. Plast. Surg. 44, 522ā528.
Liechty, K. W., Nesbit, M., Herlyn, M., Radu, A., Adzick, N. S., and Crombleholme, T. M. (1999) Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J. Invest. Dermatol. 113, 375ā383.
Felgner, P. L. and Rhodes, G. (1991) Gene therapeutics. Nature 349, 351,352.
Chen, C. and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745ā2752.
Pagano, J. S., McCutchan, J. H., and Vaheri, A. (1967) Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J. Virol. 1, 891ā897.
Neumann, E., Schaefer-Ridder, M., Wang, Y., and Hofschneider, P. H. (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1, 841ā845.
Capecchi, M. R. (1980) High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22, 479ā488.
Eriksson, E., Yao, F., Svensjo, T., Winkler, T., Slama, J., Macklin, M. D., Andree, C., McGregor, M., Hinshaw, V., and Swain, W. F. (1998) In vivo gene transfer to skin and wound by microseeding. J. Surg. Res. 78, 85ā91.
Ciernik, I. F., Krayenbuhl, B. H., and Carbone, D. P. (1996). Puncture-mediated gene transfer to the skin. Hum. Gene Ther. 7, 893ā899.
Yang, N. S. (1992) Gene transfer into mammalian somatic cells in vivo. Crit. Rev. Biotechnol. 12, 335ā356.
Yang, N. S. and Sun, W. H. (1995) Gene gun and other non-viral approaches for cancer gene therapy. Nat. Med. 1, 481ā483.
Yang, N. S., McCabe, D. E., and Swain, W. F. (1997) Methods for particle-mediated gene transfer into skin, in Gene Therapy Protocols (Robinson, P. D., ed.), Humana, Totowa, NJ, pp. 281ā296.
Klein, R. M., Wolf, E. D., Wu, R., and Sanford, J. C. (1992) High-velocity microprojectiles for delivering nucleic acids into living cells. 1987. Biotechnology 24, 384ā386.
Yang, N.-S., Burkholder, J., Roberts, B., Martinelli, B., and McCabe, D. (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568ā9572.
Prokop, A., Kozlov, E., Carlesso, G., and Davidson, J. M. (2001) Hydrogel-based colloidal polymeric systems for protein and drug delivery: physical and chemical characterization, permeability control and applications. Adv. Polymer Sci. 160, 119ā173.
Nanney, L. B., Paulsen, S., Davidson, M. K., Cardwell, N. L., Whitsitt, J. S., and Davidson, J. M. (2000) Boosting epidermal growth factor receptor expression by gene gun transfection stimulates epidermal growth in vivo. Wound Rep. Reg. 8, 117ā127.
Benn, S. I., Whitsitt, J. S., Broadley, K. N., Nanney, L. B., Perkins, D., He, L., Patel, M., Morgan, J. R., Swain, W. F., and Davidson, J. M. (1996) Particle-mediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin. J. Clin. Invest. 98, 2894ā2902.
Cheng, L., Ziegelhoffer, P. R., and Yang, N.-S. (1993) In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455ā4459.
Eming, S. A., Whitsitt, J. S., He, L., Krieg, T., Morgan, J. R., and Davidson, J. M. (1999) Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J. Invest. Dermatol. 112, 297ā302.
Lu, B., Scott, G., and Goldsmith, L. A. (1996) A model for keratinocyte gene therapy: preclinical and therapeutic considerations. Proc. Assoc. Am. Physician 108, 165ā172.
Andree, C., Swain, W. F., Page, C. P., Macklin, M. D., Slama, J., Hatzis, D., and Eriksson, E. (1994) In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc. Natl. Acad. Sci. USA 91, 12,188ā12,192.
Sun, L., Xu, L., Chang, H., Henry, F. A., Miller, R. M., Harmon, J. M., and Nielsen, T. B. (1997) Transfection with aFGF cDNA improves wound healing. J. Invest. Dermatol. 108, 313ā318.
Mahvi, D. M., Burkholder, J. K., Turner, J., Culp, J., Malter, J. S., Sondel, P. M., and Yang, N. S. (1996) Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum. Gene Ther. 7, 1535ā1543.
Haynes, J. R. (1999) Genetic vaccines. Infect. Dis. Clin. North Am. 13, 11ā26.
Olsen, C. W. (2000) DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza. Vet. Microbiol. 74, 149ā164.
Johnston, S. A. and Tang, D. C. (1993) The use of microparticle injection to introduce genes into animal cells in vitro and in vivo. Genet. Eng. 15, 225ā236.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1995) DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17, 79ā83.
Tuting, T., Gambotto, A., Baar, J., Davis, I. D., Storkus, W. J., Zavodny, P. J., Narula, S., Tahara, H., Robbins, P. D., and Lotze, M. T. (1997) Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models. Gene Ther. 4, 1053ā1060.
Tuting, T., Storkus, W. J., and Falo, L. D. Jr. (1998) DNA immunization targeting the skin: molecular control of adaptive immunity. J. Invest. Dermatol. 111, 183ā188.
Elder, E. M., Lotze, M. T., and Whiteside, T. L. (1996) Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer. Hum. Gene Ther. 7, 479ā487.
Rakhmilevich, A. L., Turner, J., Ford, M. J., McCabe, D., Sun, W. H., Sondel, P. M., Grota, K., and Yang, N. S. (1996) Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl. Acad. Sci. USA 93, 6291ā6296.
Pierce, G. F., Mustoe, T. A., Senior, R. M., Reed, J., Griffin, G. C., Thomason, A., and Deuel, T. F. (1988) In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J. Exp. Med. 167, 974ā987.
Bryant, M., Drew, G. M., Houston, P., Hissey, P., Campbell, C. J., and Braddock, M. (2000) Tissue repair with a therapeutic transcription factor. Hum. Gene Ther. 11, 2143ā2158.
Bittner, M., Halle, J.-P., Regenbogen, J., Hof, P., Dopazo, A., Reitmaier, B., Werner, S., DasGupta, J., Davidson, J., and Goppelt, A. (2001) Identification of target genes for the development of innovative drugs to heal chronic wounds. Wound Rep. Reg. 9, 146.
Yayon, A. and Klagsbrun, M. (1990) Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proc. Natl. Acad. Sci. USA 87, 5346ā5350.
Contag, C. H., Contag, P. R., Mullins, J. I., Spilman, S. D., Stevenson, D. K., and Benaron, D. A. (1995) Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18, 593ā603.
Contag, P. R., Olomu, I. N., Stevenson, D. K., and Contag, C. H. (1998) Bioluminescent indicators in living mammals. Nat. Med. 4, 245ā247.
Bou-Gharios, G., Garrett, L. A., Rossert, J., Niederreither, K., Eberspaecher, H., Smith, C., Black, C., and Crombrugghe, B. (1996) A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice. J. Cell. Biol. 134, 1333ā1344.
Chatziantoniou, C., Boffa, J. J., Ardaillou, R., and Dussaule, J. C. (1998) Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice: role of endothelin. J. Clin. Invest. 101, 2780ā2789.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Davidson, J.M., Eming, S.A., Dasgupta, J. (2003). Particle-Mediated Gene Therapy of Wounds. In: DiPietro, L.A., Burns, A.L. (eds) Wound Healing. Methods in Molecular Medicineā¢, vol 78. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-332-1:433
Download citation
DOI: https://doi.org/10.1385/1-59259-332-1:433
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-999-5
Online ISBN: 978-1-59259-332-3
eBook Packages: Springer Protocols